# ciprofloxacin hydrochloride and hydrocortisone

NDC: 0713-0851
Generic name: ciprofloxacin hydrochloride and hydrocortisone
Labeler / Manufacturer: Cosette Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION/ DROPS
Routes: AURICULAR (OTIC)
Marketing started: 20251204

FDA application: ANDA218273

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 2 mg/mL
- HYDROCORTISONE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0713-0851"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0713-0851
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6848cb55-7ca4-40ca-9751-f1fc262b8336